PNH


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.

PNH

Paroxysmal nocturnal hemoglobinuria, see there.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

PNH

Abbreviation for paroxysmal nocturnal hemoglobinuria.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012

PNH

Abbrev. for PAROXYSMAL NOCTURNAL HAEMOLGLOBINURIA.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005

Paroxysmal nocturnal hemoglobinuria (PNH)

A rare complement disorder characterized by episodes of red blood cell destruction (hemolysis) and blood in the urine (hemoglobinuria) that is worse at night.
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.
References in periodicals archive ?
Patients with PNH present clinical features of unexplained hemolytic anemia like fatigue, jaundice and red colored urine.
All patients had PNH diagnosed by flow cytometry, and 61% had begun eculizumab therapy before conception.
Em outro enfoque, a pesquisa ressalta a utilizacao de rede de contatos como uma das estrategias para implantar os dispositivos da PNH em uma instituicao hospitalar.
PNH is accepting toy and gift card donations at the office, located at 70 James St., Suite 153A.
De este modo, han sido el PLH y PNH, como partidos gobernantes presentes en todo el territorio nacional, los que han conservado el monopolio de la representacion a traves de la gestion de distintos tipos de recursos estatales.
This 26-week extension study, which is still ongoing, further evaluated Soliris in Japanese patients with PNH and allowed for a comparison with the results from the Phase III, multinational trials conducted in the United States and Europe.
* ULTOMIRIS - Subcutaneous: Dosing is underway in a single, PK-based Phase 3 study of ULTOMIRIS delivered subcutaneously once per week to support registration in PNH and aHUS.
According to report published by Grand View Research, The global paroxysmal nocturnal hemoglobinuria (PNH) treatment market size was valued at USD 2.24 billion in 2017.
'First, we completed enrollment in the Phase 3 PEGASUS trial for APL-2 in patients with PNH and will release top-line data in December 2019.
Peripheral nerve hyper-excitability (PNH) is characterized by muscle twitching at rest that results from repetitive motor unit action potentials that have a peripheral origin.